42 results
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
Guidelines for Perioperative ... Management of Antirheumatic ... Medication in Patients ... #rheumatology #medications ... #pharmacology #
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
#Antianginal #Medications ... #Cardiology #Pharmacology ... #Management #Therapy
Therapy for AL Amyloidosis 2019 
 - Antibodies (Plasma cells) 
 - Proteasome Inhibitors 
 -
Therapy for AL Amyloidosis ... ALAmyloidosis #Therapy ... #Medications #Therapies ... #Pharmacology # ... Management #Classes
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Prophylaxis) Indication ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
Drug Treatment of Anaphylaxis and Allergic Reactions
First-Line Therapy 
 - Epinephrine 
 - Oxygen 
 -
Reactions First-Line Therapy ... Second-Line Therapy ... #Anaphylaxis #Management ... #Pharmacology # ... Table #Medications
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... : - Triple Therapy ... already on triple therapy ... #Roflumilast #Indications ... #Pharmacology #
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... and risks, and therapy ... #pharmacology #pharmacotherapy ... table #comparison #management ... #medications #diabetes
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... ActiveTB #RIPE #Therapy ... #regimens #medications ... #pharmacology # ... IDSA #Guidelines
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis Indication ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Clinical Disease Indication ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology